NPC
LJPC

National Planning Corporation’s La Jolla Pharmaceutical Company LJPC Stock Holding History

National Planning Corporation’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,150
Closed -$562K – 704
2017
Q3 		$562K Sell
16,150
-1,275
-7% -$41K 0.05% 344
2017
Q2 		$523K Sell
17,425
-100
-0.6% -$2.87K 0.04% 393
2017
Q1 		$521K Hold
17,525
– – 0.04% 372
2016
Q4 		$341K Hold
17,525
– – 0.03% 469
2016
Q3 		$305K Hold
17,525
– – 0.02% 478
2016
Q2 		$314K Sell
17,525
-1,000
-5% -$17.9K 0.02% 485
2016
Q1 		$289K Sell
18,525
-500
-3% -$8.92K 0.03% 478
2015
Q4 		$288K Buy
19,025
+375
+2% +$10.2K 0.02% 529
2015
Q3 		$533K Buy
18,650
+400
+2% +$12.6K 0.05% 331
2015
Q2 		$446K Hold
18,250
– – 0.04% 386
2015
Q1 		$342K Buy
+18,250
New +$370K 0.03% 453

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

National Planning Corporation's LJPC Position: Q4 2017 in Review

National Planning Corporation sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2017, closing a stake of 16,150 shares — an estimated $562K sold.

National Planning Corporation first reported a position in LJPC in Q1 2015 and held it in 11 quarters. The position peaked at $562K in Q3 2017. 93 funds tracked by Wall St. Rank hold LJPC as of Q4 2017.

  • National Planning Corporation reported no remaining La Jolla Pharmaceutical Company position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 16,150 La Jolla Pharmaceutical Company shares in Q4 2017, an estimated $562K.
  • National Planning Corporation first reported a position in La Jolla Pharmaceutical Company in Q1 2015 and held it in 11 quarters.
  • National Planning Corporation's La Jolla Pharmaceutical Company position peaked at $562K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.